Blog Voices from the Frontlines
Jeff Sessions Is Really Going to Hate the World Health Organization’s First-Ever Marijuana Review - Americans for Safe Access
By Jackie Flynn Mogensen for Mother Jones
The World Health Organization met in Geneva, Switzerland, this week to review a first-of-its-kind report on the health and safety of cannabis, and President Donald Trump’s Justice Department will almost certainly not be thrilled with the report’s finding that marijuana is a “relatively safe drug.”
The report, compiled by a team of international cannabis experts and presented to the Expert Committee on Drug Dependence, is the first of many steps by the WHO to ultimately deliver a recommendation to the UN secretary-general on the “need for and level of international control” of cannabis, which could have a major impact on marijuana legislation internationally. Cannabis is currently classified under the same category as heroin and cocaine.
“If the scheduling of cannabis changes at an international level, there’s nothing that will happen immediately,” says Steph Sherer, executive director of Americans for Safe Access, a cannabis advocacy group. Sherer also testified at the committee meeting this week. She told Mother Jones, however, that a scheduling change would indicate “a global openness to utilizing cannabis therapeutics in natural health strategies.”
Veterans deserve equal and safe access to medical cannabis. Join us and tell your Member of Congress to support equal access for all veterans!
Senators Warren and Gardner Release STATES Act to Respect State Cannabis Laws - Americans for Safe Access
Washington, DC — U.S. Senators Elizabeth Warren (D-MA) and Cory Gardner (R-CO) introduced the Strengthening the Tenth Amendment Through Entrusting States Act (STATES Act) to respect state determinations about cannabis policy. The bill was also introduced in the House of Representatives by David Joyce (R-OH) and Earl Blumenauer (D-OR).
With Trump’s Support, STATES Act Could End Nationwide Cannabis Prohibition - Americans for Safe Access
A bipartisan group of senators and representatives introduced a historic bill this morning that could change the cannabis legalization landscape across the United States.
n a move that’s been anticipated for weeks, Sen. Cory Gardner (R-CO) and Sen. Elizabeth Warren (D-MA), and Rep. David Joyce (R-OH) and Earl Blumenauer (D-OR) introduced the Strengthening the Tenth Amendment Entrusting States (STATES) Act this morning on Capitol Hill. The measure would exempt state-legal marijuana from the Controlled Substances Act, allowing every state to legalize and regulate cannabis (or keep it illegal) as they see fit.
After hosting scores of community forums across the U.S. to gather input from patients on the issues most important to them, ASA created a matrix to analyze medical cannabis laws in order to evaluate and grade each component based on patient needs. As more states adopt and improve medical cannabis laws, we hope that state legislators and regulators will use this matrix to help them design comprehensive, helpful laws for patients, particularly laws that will help reduce the number of preventable opioid deaths.
The report uses a point system to grade each state’s medical marijuana law on:
- Patients' Rights and Civil Protections From Discrimination
- Access to Medicine
- Ease of Navigation
- Consumer Safety and Provider Requirements
In the June 2018 Issue:
- ASA Brings Citizen Lobbyists to Capitol Hill
- Opioid Crisis Focus of Sixth Annual Unity Conference
- PFC Federal Raid Training Prepares Industry
- Utah Medical Cannabis Initiative Overcomes Opposition
- Pennsylvania Expands Qualifying Products and Conditions
- Activist Profiles: 2018 ASA Excellence Award Winners
- ACTION ALERT: Veterans Deserve Safe Access to Medical Cannabis
International Medical Cannabis Advocates Address WHO Committee to Reschedule Cannabis - Americans for Safe Access
This week medical cannabis patient advocacy groups from Argentina, Mexico, Uruguay, France, Germany, New Zealand, the Netherlands, South Africa, and the United States travelled to Geneva, Switzerland to present to world leaders their recommendations for rescheduling cannabis at the 40th meeting of the World Health Organization's (WHO) Expert Committee on Drug Dependence (ECDD).
The air was filled with excitement that the ECDD was finally beginning the process of looking at new information regarding cannabis as medicine. A process that has been long overdue considering the original scheduling of cannabis was created based on a report produced by the Health Committee of the League of Nations back in 1935. International bodies have been calling on the WHO to address the scheduling of cannabis for almost a decade, and the WHO finally listened.
Contact your Senators and Representative today to ask them to ensure the CJS Medical Marijuana Amendment is included in the FY2018 appropriations package AND end the federal conflict once and for all by sponsoring the CARERS Act.
International Medical Cannabis Advocates Address WHO Committee Set to Advise UN
Geneva, Switzerland — Yesterday, Americans for Safe Access (ASA), along with members of the International Medical Cannabis Patients Coalition (IMCPC), attended and delivered testimony at the 40th meeting of the World Health Organization's (WHO) Expert Committee on Drug Dependence (ECDD) being held in Geneva, Switzerland, June 4-7th, 2018.
In a milestone moment for medical cannabis patients, the ECDD will be reviewing and assessing the medical uses and harms of Cannabis, in order to recommend the most appropriate classification to be applied internationally. The agenda of the meeting is dedicated to carrying out pre-reviews of cannabis and cannabis-related substances. Members of ASA and IMCPC produced and delivered 1 Critical Review and 3 Pre-Review reports on Cannabidiol (CBD), Cannabis plant and cannabis resin, Extracts and tinctures of cannabis, and Delta-9-tetrahydrocannabinol (THC), which included references and recommendations for the committee to use in their review.
By Christopher Moraff for The Daily Beast
Dr. Jahan Marcu, Senior Scientist at Americans for Safe Access, a marijuana advocacy group, calls the reemergence of synthetic cannabinoids a “product safety nightmare.”
“It’s like ordering a drink and not knowing if it’s 0 percent alcohol or full proof,” he said.